Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
JOR Spine|October 2, 2023
The research landscape of immunology research in spinal cord injury from 2012 to 2022Bowen Zheng, Yirui Kuang, Dun Yuan, et al.International Journal of Surgery (London, England)|November 11, 2025
Clinical, molecular characteristics and telomere maintaining mechanism of spinal cord glioma with or without H3 K27M mutation: a prognostic and experimental studyHaoxuan Huang, Yue Gou, Yirui Kuang, et al.Frontiers in Immunology|November 29, 2023
A prognostic signature based on snoRNA predicts the overall survival of lower-grade glioma patientsYi Zhou, Wen Yin, Yirui Kuang, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 25, 2023
miR-33b in human cancer: Mechanistic and clinical perspectivesWenlong Zhang, Bincan Jiang, Hecheng Zhu, et al.International Journal of Biological Macromolecules|August 9, 2025
Pan-cancer analysis and experimental validation revealed that prognostic biomarker APOBEC3C may promote M2-type macrophage polarization and prevent R-loop accumulation in gliomaWen Yin, Yirui Kuang, Zhaoqi Xin, et al.Frontiers in Immunology|May 8, 2023
Classification related to immunogenic cell death predicts prognosis, immune microenvironment characteristics, and response to immunotherapy in lower-grade gliomasYirui Kuang, Bincan Jiang, Hecheng Zhu, et al.Frontiers in Surgery|August 8, 2022
A practical and economical method for frontal sinus reconstruction after frontal craniotomy: A single-center experience with 140 patientsYouwei Guo, Xianyong Fu, Wen Yin, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 30, 2022
The role of lncRNA just proximal to XIST (JPX) in human disease phenotypes and RNA methylation: The novel biomarker and therapeutic target potentialYirui Kuang, Wenyue Shen, Hecheng Zhu, et al.Heliyon|March 11, 2024
Integrated profiling identifies ferredoxin 1 as an immune-related biomarker of malignant phenotype in gliomaDongcheng Xie, Hailong Huang, Youwei Guo, et al.Cerebrovascular Diseases (Basel, Switzerland)|November 13, 2025
Inhibition of ADORA3 Accelerates Hematoma Resolution and Neurological Recovery after ICHQi Yu, Xian Yu, Yirui Kuang, et al.Pageof 2